Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Dow
Medtronic
Baxter

Last Updated: September 28, 2022

Investigational Drug Information for Rhamnose


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Rhamnose?

Rhamnose is an investigational drug.

There have been 3 clinical trials for Rhamnose. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2013.

The most common disease conditions in clinical trials are Crohn Disease, Malnutrition, and Premature Birth. The leading clinical trial sponsors are Dhaka Medical College, University of Virginia, and University of Washington.

Recent Clinical Trials for Rhamnose
TitleSponsorPhase
Oral Administration of MB-102 Versus Dual Sugar Testing for Gut PermeabilityMediBeaconEarly Phase 1
The Bangladesh Environmental Enteric Dysfunction StudyBangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshN/A
The Bangladesh Environmental Enteric Dysfunction StudyBill and Melinda Gates FoundationN/A

See all Rhamnose clinical trials

Clinical Trial Summary for Rhamnose

Top disease conditions for Rhamnose
Top clinical trial sponsors for Rhamnose

See all Rhamnose clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Express Scripts
Dow
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.